We are live on ! Find out more
WCBA

Weaver C. Barksdale & Associates Portfolio holdings

AUM $105M
1-Year Est. Return 13.81%
This Fund
S&P 500
This Quarter Est. Return
-1.4%
1 Year Est. Return
+13.81%
3 Year Est. Return
+40.08%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$107M
AUM Growth
-$6.45M
Cap. Flow
-$3.31M
Cap. Flow %
-3.09%
Top 10 Hldgs %
20.92%
Holding
63
New
1
Increased
5
Reduced
55
Closed
1

Top Buys

Rank Stock Value
1
LYB icon
LyondellBasell Industries
LYB
+$1.96M
2
SCHW
Charles Schwab
SCHW
+$523K
3
ORI icon
Old Republic International
ORI
+$370K
4
JNJ icon
Johnson & Johnson
JNJ
+$258K
5
LOW icon
Lowe's Companies
LOW
+$238K

Top Sells

Rank Stock Value
1
DGX icon
Quest Diagnostics
DGX
+$2.27M
2
MRK icon
Merck
MRK
+$119K
3
AMP icon
Ameriprise Financial
AMP
+$117K
4
NXST icon
Nexstar Media Group
NXST
+$114K
5
UL icon
Unilever
UL
+$106K

Sector Composition

Rank Sector Weight
1 Financials 19.82%
2 Healthcare 15.66%
3 Industrials 11.14%
4 Energy 9.77%
5 Technology 9.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GILD icon
1
Gilead Sciences
GILD
$162B
$2.4M 2.25%
28,953
-1,151
-4% -$95.3K
AVGO icon
2
Broadcom
AVGO
$1.83T
$2.31M 2.16%
36,070
-1,690
-4% -$102K
ITW icon
3
Illinois Tool Works
ITW
$82.3B
$2.27M 2.12%
9,334
-454
-5% -$106K
UL icon
4
Unilever
UL
$138B
$2.26M 2.11%
38,644
-1,868
-5% -$106K
AMP icon
5
Ameriprise Financial
AMP
$48.4B
$2.23M 2.08%
7,263
-356
-5% -$117K
NXST icon
6
Nexstar Media Group
NXST
$5.84B
$2.23M 2.08%
12,893
-620
-5% -$114K
ABBV icon
7
AbbVie
ABBV
$449B
$2.19M 2.05%
13,749
-668
-5% -$102K
SNA icon
8
Snap-on
SNA
$21.3B
$2.18M 2.04%
8,831
-423
-5% -$103K
PSX icon
9
Phillips 66
PSX
$84B
$2.16M 2.02%
21,304
-1,028
-5% -$105K
ORI icon
10
Old Republic International
ORI
$10.5B
$2.16M 2.01%
86,313
+14,717
+21% +$370K
GPC icon
11
Genuine Parts
GPC
$17.2B
$2.14M 2%
12,778
-622
-5% -$105K
OGE icon
12
OGE Energy
OGE
$9.83B
$2.13M 1.99%
56,653
-2,725
-5% -$102K
IPG
13
DELISTED
Interpublic Group of Companies
IPG
$2.13M 1.99%
57,146
-2,699
-5% -$97K
LOW icon
14
Lowe's Companies
LOW
$117B
$2.1M 1.96%
10,500
+1,174
+13% +$238K
MRK icon
15
Merck
MRK
$323B
$2.1M 1.96%
19,727
-1,103
-5% -$119K
TXN icon
16
Texas Instruments
TXN
$252B
$2.04M 1.91%
10,960
-523
-5% -$92K
CVX icon
17
Chevron
CVX
$388B
$2.02M 1.89%
12,409
-600
-5% -$101K
O icon
18
Realty Income
O
$59.5B
$2.02M 1.88%
31,823
-1,543
-5% -$100K
LMT icon
19
Lockheed Martin
LMT
$134B
$2M 1.87%
4,239
-205
-5% -$96.1K
AFL icon
20
Aflac
AFL
$65.1B
$2M 1.87%
30,938
-1,498
-5% -$103K
AMGN icon
21
Amgen
AMGN
$207B
$1.99M 1.86%
8,213
-398
-5% -$97.7K
LYB icon
22
LyondellBasell Industries
LYB
$19.9B
$1.98M 1.85%
+21,044
New +$1.96M
SJM icon
23
J.M. Smucker
SJM
$12.9B
$1.93M 1.81%
12,275
-602
-5% -$91.4K
MSFT icon
24
Microsoft
MSFT
$3.43T
$1.92M 1.8%
6,667
-321
-5% -$81.9K
QCOM icon
25
Qualcomm
QCOM
$156B
$1.9M 1.78%
14,920
-599
-4% -$74.5K
1
2 3

Similar funds

EW
Expressive Wealth Chicago, Illinois $105M AUM
ANBOT
American National Bank of Texas Richardson, Texas $105M AUM
P
Palladiem Bryn Mawr, Pennsylvania $105M AUM
SPW
Signet Private Wealth Chicago, Illinois $105M AUM
SHF
Safe Harbor Fiduciary Pensacola, Florida $105M AUM
NS
Northland Securities Minneapolis, Minnesota $105M AUM
ACA
Alpha Capital Advisors Bangor, Maine $105M AUM
HA
Helium Advisors Everett, Washington $105M AUM 15.41% 1-Year Est. Return

Weaver C. Barksdale & Associates's Q1 2023 Portfolio in Review

As of Q1 2023, Weaver C. Barksdale & Associates held 63 positions worth $107M, down 5.7% from $113M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Weaver C. Barksdale & Associates withdrew a net $3.31M in Q1 2023, closing 1 position and reducing 55 holdings. Its most notable exit was Quest Diagnostics, an estimated $2.27M position sold in full.

By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Weaver C. Barksdale & Associates opened a new position in LyondellBasell Industries worth $1.98M.

  • Weaver C. Barksdale & Associates's largest Q1 2023 buy was LyondellBasell Industries: 21,044 shares worth $1.98M.
  • Weaver C. Barksdale & Associates added most to Charles Schwab in Q1 2023, an estimated $523K increase.
  • Weaver C. Barksdale & Associates's biggest Q1 2023 reduction was Merck, cutting an estimated $119K.
  • Weaver C. Barksdale & Associates fully exited Quest Diagnostics in Q1 2023, selling an estimated $2.27M.
  • Weaver C. Barksdale & Associates's ten largest holdings make up 21% of its $107M portfolio in Q1 2023.
  • Weaver C. Barksdale & Associates opened 1 new position and closed 1 in Q1 2023.
  • Weaver C. Barksdale & Associates's portfolio value fell 5.7% quarter-over-quarter to $107M.

Based on Weaver C. Barksdale & Associates's 13F filing for Q1 2023, filed 12 May 2023.